Skip to main content
Journal cover image

Assessing neurocognitive dysfunction in cranial radiotherapy: can cognitive event-related potentials help?

Publication ,  Journal Article
Pearlstein, RD; Whitten, C; Haerich, P
Published in: Technol Cancer Res Treat
April 2006

Cognitive changes are common sequelae of cancer and cancer treatment, particularly in patients receiving cranial radiotherapy (RT). These effects are typically assessed by subjective clinical examination or using objective neuropsychological tests. Biologically based neurophysiological methods have been increasingly applied to the study of cognitive processing in neuropsychiatric and neurological disorders and as objective measures of cognitive status for patients with dementia. These methods detect the activation of neural circuits that directly mediate cognitive function in the human brain and include metabolic and electrophysiology based techniques. Neuroimaging procedures such as 18FDG PET and more recently fMRI, which detect metabolic activation associated with cognitive processing, provide excellent spatial resolution and can be directly correlated with neuroradiological findings associated with cranial RT neurotoxicity. Clinical electrophysiology procedures such as cognitive event-related potentials (ERP), which detect the neuronal electrical activity associated with cognitive processing, offer excellent temporal resolution at low cost. Cognitive ERP techniques are already being used to assess severity and progression of cognitive dysfunction in patients with vascular and degenerative dementias, but have been largely overlooked in studies of radiation-related cognitive impairments. We review these various electrophysiological methods in the context of their relevance to assessing cranial RT effects on cognitive function, and provide recommendations for a neurophysiological approach to supplement current neuropsychological tests for RT cognitive impairments. This technology is well suited for clinical assessment of neurocognitive sequelae of cancer and should provide new insights into the mechanism of RT-related cognitive dysfunction.

Duke Scholars

Published In

Technol Cancer Res Treat

DOI

ISSN

1533-0346

Publication Date

April 2006

Volume

5

Issue

2

Start / End Page

109 / 125

Location

United States

Related Subject Headings

  • Oncology & Carcinogenesis
  • Humans
  • Disease Progression
  • Cranial Irradiation
  • Cognition Disorders
  • Brain Neoplasms
  • 3211 Oncology and carcinogenesis
  • 1112 Oncology and Carcinogenesis
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Pearlstein, R. D., Whitten, C., & Haerich, P. (2006). Assessing neurocognitive dysfunction in cranial radiotherapy: can cognitive event-related potentials help? Technol Cancer Res Treat, 5(2), 109–125. https://doi.org/10.1177/153303460600500205
Pearlstein, Robert D., Crystal Whitten, and Paul Haerich. “Assessing neurocognitive dysfunction in cranial radiotherapy: can cognitive event-related potentials help?Technol Cancer Res Treat 5, no. 2 (April 2006): 109–25. https://doi.org/10.1177/153303460600500205.
Pearlstein RD, Whitten C, Haerich P. Assessing neurocognitive dysfunction in cranial radiotherapy: can cognitive event-related potentials help? Technol Cancer Res Treat. 2006 Apr;5(2):109–25.
Pearlstein, Robert D., et al. “Assessing neurocognitive dysfunction in cranial radiotherapy: can cognitive event-related potentials help?Technol Cancer Res Treat, vol. 5, no. 2, Apr. 2006, pp. 109–25. Pubmed, doi:10.1177/153303460600500205.
Pearlstein RD, Whitten C, Haerich P. Assessing neurocognitive dysfunction in cranial radiotherapy: can cognitive event-related potentials help? Technol Cancer Res Treat. 2006 Apr;5(2):109–125.
Journal cover image

Published In

Technol Cancer Res Treat

DOI

ISSN

1533-0346

Publication Date

April 2006

Volume

5

Issue

2

Start / End Page

109 / 125

Location

United States

Related Subject Headings

  • Oncology & Carcinogenesis
  • Humans
  • Disease Progression
  • Cranial Irradiation
  • Cognition Disorders
  • Brain Neoplasms
  • 3211 Oncology and carcinogenesis
  • 1112 Oncology and Carcinogenesis